Stay updated on Pembrolizumab Neoadjuvant in HCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Neoadjuvant in HCC Clinical Trial page.

Latest updates to the Pembrolizumab Neoadjuvant in HCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a platform update. No study information or content on the page is changed.SummaryDifference0.1%

- Check18 days agoChange DetectedThe revision note now shows v3.6.2, replacing the previous v3.6.0. This indicates a new site release/version update rather than a substantive change to page content.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page lists Masatoshi Kudo as the investigator (without the institution) and introduces Last verified metadata, while adding help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updating the revision from v3.5.5 to v3.6.0.SummaryDifference2%

- Check39 days agoChange DetectedRevision badge updated from v3.5.4 to v3.5.5, representing a minor page update without changes to study content or results.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision tag 'Revision: v3.5.4' was added and the previous tag 'Revision: v3.5.3' was removed, updating the page's revision history.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page’s revision/version number was updated from v3.5.2 to v3.5.3. This indicates a site build or metadata update without changing the underlying study information presented.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Neoadjuvant in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Neoadjuvant in HCC Clinical Trial page.